Canonical Wnt Pathway Maintains Blood-Brain Barrier Integrity upon Ischemic Stroke and Its Activation Ameliorates Tissue Plasminogen Activator Therapy
- 134 Downloads
Stroke induces blood-brain barrier (BBB) breakdown, which promotes complications like oedema and hemorrhagic transformation. Administration of recombinant tissue plasminogen activator (rtPA) within a therapeutic time window of 4.5 h after stroke onset constitutes the only existing treatment. Beyond this time window, rtPA worsens BBB breakdown. Canonical Wnt pathway induces BBB formation and maturation during ontogeny. We hypothesized that the pathway is required to maintain BBB functions after stroke; thus, its activation might improve rtPA therapy. Therefore, we first assessed pathway activity in the brain of mice subjected to transient middle cerebral artery occlusion (MCAo). Next, we evaluated the effect of pathway deactivation early after stroke onset on BBB functions. Finally, we assessed the impact of pathway activation on BBB breakdown associated to delayed administration of rtPA. Our results show that pathway activity is induced predominately in endothelial cells early after ischemic stroke. Early deactivation of the pathway using a potent inhibitor, XAV939, aggravates BBB breakdown and increases hemorrhagic transformation incidence. On the other hand, pathway activation using a potent activator, 6-bromoindirubin-3′-oxime (6-BIO), reduces the incidence of hemorrhagic transformation associated to delayed rtPA administration by attenuating BBB breakdown via promotion of tight junction formation and repressing endothelial basal permeability independently of rtPA proteolytic activity. BBB preservation upon pathway activation limited the deleterious effects of delayed rtPA administration. Our study demonstrates that activation of the canonical Wnt pathway constitutes a clinically relevant strategy to extend the therapeutic time window of rtPA by attenuating BBB breakdown via regulation of BBB-specific mechanisms.
KeywordsIschemic stroke Hemorrhagic transformation Blood-brain barrier Brain endothelial cells Tissue plasminogen activator Canonical Wnt pathway Tight junctions
We would like to thank Mrs. Revathy Guruswamy for performing some of the MCAo surgeries, Dr. Nathalie Vernoux for preparing the brain samples for TEM, and Mrs. Julie-Christine Lévesque at the Bio-Imaging Platform of CRCHU de Québec for technical assistance.
This study was financially supported by grants from the Natural Sciences and Engineering Research Council of Canada (NSERC), Heart and Stroke Foundation of Canada (HSFC), and Fonds de recherche du Québec - Santé (FRQS) (all to AEA). NJL was supported by a scholarship from the NSERC, and a scholarship from the Fondation du CHU de Québec. KP was supported by a scholarship from the Fondation du CHU de Québec. MET is a Canada Research Chair (Tier 2) in Neuroimmune Plasticity in Health and Therapy.
Compliance with Ethical Standards
Animal experiments were performed according to the Canadian Council on Animal Care guidelines, as administered by the Université Laval Animal Welfare Committee.
Conflict of Interest
The authors declare that they have no conflict of interest.
- 7.Garbuzova-Davis S, Haller E, Williams SN, Haim ED, Tajiri N, Hernandez-Ontiveros DG, Frisina-Deyo A, Boffeli SM et al (2014) Compromised blood-brain barrier competence in remote brain areas in ischemic stroke rats at the chronic stage. J Comp Neurol 522:3120–3137. https://doi.org/10.1002/cne.23582 CrossRefPubMedPubMedCentralGoogle Scholar
- 9.Wang X, Tsuji K, Lee SR, Ning M, Furie KL, Buchan AM, Lo EH (2004) Mechanisms of hemorrhagic transformation after tissue plasminogen activator reperfusion therapy for ischemic stroke. Stroke 35:2726–2730. https://doi.org/10.1161/01.STR.0000143219.16695.af CrossRefPubMedGoogle Scholar
- 10.Del Zoppo GJ, Saver JL, Jauch EC, Adams HP Jr, American Heart Association Stroke C (2009) Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association. Stroke 40:2945–2948. https://doi.org/10.1161/STROKEAHA.109.192535 CrossRefPubMedPubMedCentralGoogle Scholar
- 11.Sussman ES, Connolly ES Jr (2013) Hemorrhagic transformation: a review of the rate of hemorrhage in the major clinical trials of acute ischemic stroke. Front Neurol 4:69. doi: https://doi.org/10.3389/fneur.2013.00069
- 12.Zhang J, Yang Y, Sun H, Xing Y (2014) Hemorrhagic transformation after cerebral infarction: current concepts and challenges. Ann Transl Med 2(81). https://doi.org/10.3978/j.issn.2305-5839.2014.08.08
- 13.Clevers H, Nusse,R (2012) Wnt/beta-catenin signaling and disease. Cell 149:1192–1205. doi: https://doi.org/10.1016/j.cell.2012.05.012
- 15.Tran KA, Zhang X, Predescu D, Huang X, Machado RF, Gothert JR, Malik AB, Valyi-Nagy T et al (2016) Endothelial beta-catenin signaling is required for maintaining adult blood-brain barrier integrity and central nervous system homeostasis. Circulation 133:177–186. https://doi.org/10.1161/CIRCULATIONAHA.115.015982 CrossRefPubMedGoogle Scholar
- 16.Lengfeld JE, Lutz SE, Smith JR, Diaconu C, Scott C, Kofman SB, Choi C, Walsh CM et al (2017) Endothelial Wnt/beta-catenin signaling reduces immune cell infiltration in multiple sclerosis. Proc Natl Acad Sci U S A 114:E1168–E1177. https://doi.org/10.1073/pnas.1609905114 CrossRefPubMedPubMedCentralGoogle Scholar
- 17.ElAli A, Urrutia A, Rubio-Araiz A, Hernandez-Jimenez M, Colado MI, Doeppner TR, Hermann DM (2012) Apolipoprotein-E controls adenosine triphosphate-binding cassette transporters ABCB1 and ABCC1 on cerebral microvessels after methamphetamine intoxication. Stroke 43:1647–1653. https://doi.org/10.1161/STROKEAHA.111.648923 CrossRefPubMedGoogle Scholar
- 18.Wang YZ, Yamagami T, Gan Q, Wang Y, Zhao T, Hamad S, Lott P, Schnittke N et al (2011) Canonical Wnt signaling promotes the proliferation and neurogenesis of peripheral olfactory stem cells during postnatal development and adult regeneration. J Cell Sci 124:1553–1563. https://doi.org/10.1242/jcs.080580 CrossRefPubMedPubMedCentralGoogle Scholar
- 19.Zhao Y, Wei ZZ, Zhang JY, Zhang Y, Won S, Sun J, Yu SP, Li J et al (2017) GSK-3β inhibition induced neuroprotection, regeneration, and functional recovery after intracerebral hemorrhagic stroke. Cell Transplant 26:395–407. https://doi.org/10.3727/096368916X694364
- 20.Jean LeBlanc N, Guruswamy R, ElAli A (2018) Vascular endothelial growth factor isoform-B stimulates neurovascular repair after ischemic stroke by promoting the function of pericytes via vascular endothelial growth factor receptor-1. Mol Neurobiol 55:3611–3626. https://doi.org/10.1007/s12035-017-0478-6 CrossRefPubMedGoogle Scholar
- 23.ElAli A, Doeppner TR, Zechariah A, Hermann DM (2011) Increased blood-brain barrier permeability and brain edema after focal cerebral ischemia induced by hyperlipidemia: role of lipid peroxidation and calpain-1/2, matrix metalloproteinase-2/9, and RhoA overactivation. Stroke 42:3238–3244. https://doi.org/10.1161/STROKEAHA.111.615559 CrossRefPubMedGoogle Scholar
- 29.Benchenane K, Berezowski V, Fernández-Monreal M, Brillault J, Valable S, Dehouck MP, Cecchelli R, Vivien D et al (2005) Oxygen glucose deprivation switches the transport of tPA across the blood-brain barrier from an LRP-dependent to an increased LRP-independent process. Stroke 36:1065–1070CrossRefGoogle Scholar
- 37.Carson-Walter EB, Hampton J, Shue E, Geynisman DM, Pillai PK, Sathanoori R, Madden SL, Hamilton R et al (2005) Plasmalemmal vesicle associated protein-1 is a novel marker implicated in brain tumor angiogenesis. Clin Cancer Res 11:7643–7650. https://doi.org/10.1158/1078-0432.CCR-05-1099 CrossRefPubMedGoogle Scholar
- 40.Wang W, Li M, Wang Y, Li Q, Deng G, Wan J, Yang Q, Chen Q et al (2016) GSK-3beta inhibitor TWS119 attenuates rtPA-induced hemorrhagic transformation and activates the Wnt/beta-catenin signaling pathway after acute ischemic stroke in rats. Mol Neurobiol 53:7028–7036. https://doi.org/10.1007/s12035-015-9607-2 CrossRefPubMedGoogle Scholar